wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A
Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer
P2860
Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36880037-6F0CA2DF-8A22-4B3D-98B5-08004138824A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0049d9475d70c5cb5422e3cf772fc515506a2254
P2860
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.